Ameritas Investment Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Ameritas Investment Partners’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,835	Closed	-$7K	–	3165
2020 Q1	$7K	Hold	1,835	–	–	﹤0.01%	2716
2019 Q4	$11K	Hold	1,835	–	–	﹤0.01%	2718
2019 Q3	$14K	Hold	1,835	–	–	﹤0.01%	2590
2019 Q2	$25K	Buy	+1,835	New	+$21.2K	﹤0.01%	2329
2018 Q2	–	Sell	-1,001	Closed	-$9K	–	3079
2018 Q1	$9K	Hold	1,001	–	–	﹤0.01%	2768
2017 Q4	$13K	Hold	1,001	–	–	﹤0.01%	2673
2017 Q3	$6K	Hold	1,001	–	–	﹤0.01%	2907
2017 Q2	$17K	Buy	+1,001	New	+$19.9K	﹤0.01%	2566

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's ZYNE Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 1,835 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in ZYNE in Q2 2017 and held it in 8 quarters. The position peaked at $25K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

Ameritas Investment Partners reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Partners sold 1,835 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $7K.
Ameritas Investment Partners first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2017 and held it in 8 quarters.
Ameritas Investment Partners's Zynerba Pharmaceuticals, Inc position peaked at $25K in Q2 2019.
74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.